85 results
Page 3 of 5
8-K
EX-1.1
mmsovecxybk fst0k
28 Apr 22
Other Events
4:20pm
8-K
EX-99.2
08vcw2o31ehi
25 Apr 22
Nkarta Announces Positive Preliminary Dose Finding Data for Two Lead Engineered Natural Killer Cell Programs
7:52am
8-K
EX-99.1
9ztxy5hw
25 Apr 22
Nkarta Announces Positive Preliminary Dose Finding Data for Two Lead Engineered Natural Killer Cell Programs
7:52am
8-K
EX-99.1
uxaa8gou qk
22 Apr 22
Nkarta to Host Conference Call Highlighting Preliminary Clinical Data from
4:17pm
8-K
EX-99.1
umomtilnkam
29 Mar 22
Nkarta Appoints Manufacturing Technology Executive, Angela Thedinga, to Board of Directors
8:11am
8-K
EX-99.1
8iohxivsl5n29
17 Mar 22
Nkarta Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Highlights
4:11pm
8-K
EX-99.1
rh8n3nr87bswg
10 Nov 21
Nkarta Reports Third Quarter 2021 Financial Results and Business Update
4:14pm
8-K
EX-10.1
gk41 q6n5
22 Oct 21
Entry into a Material Definitive Agreement
4:13pm
8-K
EX-99.1
s1uvqnah tn
7 Oct 21
Nkarta Announces Updates to NKX019 and NKX101 Clinical Development Programs
4:09pm
S-3
EX-1.2
uao7n jucxn
12 Aug 21
Shelf registration
5:04pm
8-K
EX-10.1
5v3x5bz
14 Jul 21
Entry into a Material Definitive Agreement
7:07am
DEF 14A
lhpoxb3v6zuautq1slgf
22 Apr 21
Definitive proxy
12:35pm
10-K
f6chns9i6k
25 Mar 21
Annual report
12:00am
10-K
EX-10.10
2qaq0h7u
25 Mar 21
Annual report
12:00am